Region: Global
Category: Diabetes

Global Diabetes

(297 reports matching your criteria)
  • The 2026-2031 World Outlook for Blood Glucose Testing

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Blood Glucose Meters and Strips

    ... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More

  • The 2026-2031 World Outlook for Diabetes Treatment Devices

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Diabetes Diagnosis, Treatment, and Drug Delivery Devices

    ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More

  • The 2026-2031 World Outlook for Diabetes Diagnostics

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Diabetes Care Products

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Glucose Meters

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Injectable Diabetes Drugs

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Insulin Delivery Devices

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Blood Glucose Meters

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Diabetes Therapeutics

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Diabetes Monitoring and Diagnostic Devices

    ... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More

  • The 2026-2031 World Outlook for Diabetes Injection Pens for Type I Diabetes

    ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More

  • The 2026-2031 World Outlook for Diabetes Devices

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Continuous Glucose Monitoring

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Insulin Pen Needles

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • Non-Insulin Diabetes Therapeutics

    ... at a CAGR of 9.1% over the analysis period 2024-2030. DPP4 Inhibitors, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$37.9 Billion by the end of ... Read More

  • Type 1 Diabetes

    ... at a CAGR of 5.4% over the analysis period 2024-2030. Insulin Pen, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.4 Billion by the end of ... Read More

  • Insulin Storage Devices

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$996.0 Million by the end ... Read More

  • Diabetes Diagnostics

    ... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More

  • Self-Care Medical Devices

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Blood Glucose Monitors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.8 Billion by the end ... Read More

  • Artificial Intelligence (AI) in Diabetes Management

    ... reach US$21.4 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More

  • Diabetes Monitoring Devices

    ... at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the ... Read More

  • Blood Glucose Monitoring Systems

    ... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the end ... Read More

  • Insulin Delivery Systems

    ... at a CAGR of 3.2% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$7.0 Billion by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings